Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

98.95
Delayed Data
As of 4:00pm ET
 0.00 / 0.00%
Today’s Change
96.60
Today|||52-Week Range
153.15
-1.32%
Year-to-Date

Today’s Trading

Previous close98.95
Today’s open99.36
Day’s range96.60 - 99.97
Volume2,893,993
Average volume (3 months)1,600,721
Market cap$20.9B
Dividend yield--
Data as of 4:00pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)+1,700.00%
Earnings growth (this year)-329.18%
Earnings growth (next 5 years)+75.95%
Revenue growth (last year)+46.70%
P/E ratioNM
Price/Sales17.60
Price/Book44.55

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.41+0.58%
ALXNAlexion Pharmaceutic...-0.44-0.41%
BAXBaxter International...+0.37+0.58%
MYLMylan NV+0.73+2.00%
Data as of 4:15pm ET, 11/21/2017

Financials

Next reporting dateFebruary 14, 2018
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$1.1B
Annual profit (last year)$104.2M
Net profit margin9.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts